Acute promyelocytic leukemia and HIV-1 infection: Case Report and Review of the Literature

American Journal of Hematology

Volumn 77, Issue 3, 2004, Pages 287-290

  Kudva, Ganesh C ^a,b   Maliekel, Kochurani ^a   Richart, John M ^a   Batanian, Jacqueline R ^a   Grosso, Leonard E ^a   Sokol Anderson, Marcia ^a   Petruska, Paul J ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SAINT LOUIS UNIVERSITY CANCER CENTER   (United States)

Author keywords

Acute promyelocytic leukemia; Cytogenetics; HIV 1; Three way chromosomal translocation

Indexed keywords

AMOXICILLIN; ANTHRACYCLINE; ANTIRETROVIRUS AGENT; CYTARABINE; DAUNORUBICIN; IDARUBICIN; INDINAVIR; LAMIVUDINE; MERCAPTOPURINE; METHOTREXATE; MITOXANTRONE; NELFINAVIR; RETINOIC ACID; STAVUDINE; ZIDOVUDINE;

ADULT; BONE MARROW BIOPSY; CANCER COMBINATION CHEMOTHERAPY; CASE REPORT; CHROMOSOME ANALYSIS; CHROMOSOME TRANSLOCATION; HEMATURIA; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LABORATORY TEST; LEUKEMIA REMISSION; LIVER DYSFUNCTION; MAINTENANCE THERAPY; MALE; PANCYTOPENIA; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; REVIEW; SORE THROAT; TREATMENT OUTCOME;

6-MERCAPTOPURINE; ADULT; ANTHRACYCLINES; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; HIV INFECTIONS; HIV-1; HOMOSEXUALITY, MALE; HUMANS; LEUKEMIA, PROMYELOCYTIC, ACUTE; MALE; METHOTREXATE; TREATMENT OUTCOME; TRETINOIN;

EID: 7244231072     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/ajh.20192     Document Type: Review

References (13)

1. Degos L. The history of acute promyelocytic leukemia. Br J Haematol 2003;122:539-553.
2. Mitsuyasu RT, Cooper JS. AIDS-related malignancies. In: Pazdue R, Coia LR, Hoskins WJ, Wagman LD, editors. Cancer management: a multidisciplinary approach medical, surgical and radiation oncology. New York: The Oncology Group; 2003. p 609-632.
3. Sutton L, Guenel P, Tanguy M-L, et al. Acute myeloid leukemia in human immunodeficiency virus-infected adults: epidemiology, treatment feasibility and outcome. Br J Haematol 2001;112:900-908.
4. Aboulafia DM, Meneses M, Ginsberg S, Siegel MS, Howard WW, Dezube BJ. Acute myeloid leukemia in patients infected with HIV-1. AIDS 2002;16(6):865-876.
5. Calvo R, Ribera JM, Battle M, Sancho JM, Granada I, Flores A. Acute promyelocytic leukemia in a HIV seropositive patient. Leuk Lymphoma 1997;26:621-6241.
6. Gatphoh ED, Zamzachin G, Devi SB, Punyabati P. AIDS related malignant disease at regional institute of medical sciences. Indian J Pathol Microbiol 2001;44(1):1-4.
7. Tallman MS, Nabhan C, Feusner JH, Rowe JM. Acute promyelocytic leukemia: evolving therapeutic strategies. Blood 2001;99(3):759-767.
8. de Botton S, Sanz MA, Thomas X, et al. Extramedullary relapses in APL treated with ATRA and chemotherapy. Blood 2002;100(11 Suppl 1):334a.
9. Wan TS, Chim CS, So CK, Chan LC, Ma SK. Complex variant 15;17 translocations in acute promyelocytic leukemia. A case report and review of the literature. Cancer Genet Cytogenet 1999;111(2): 139-143.
10. Okoshi Y, Akiyama H, Kono N, et al. Effect of additional chromosomal abnormalities in acute promyelocytic leukemia treated with all-trans-retinoic acid: a report of 17 cases. Int J Hematol 2001;73(4):496-501.
11. Slack JL, Arthur DC, Lawrence D, et al. Secondary cytogenetic changes in acute promyelocytic leukemia-prognostic importance in patients treated with chemotherapy alone and association with the intron 3 breakpoint of the PML gene: a cancer and leukemia group B study. J Clin Oncol 1997;15(5):1786-1795.
12. Hiorns LR, Swansbury GJ, Mehta J, et al. Additional chromosome abnormalities confer worse prognosis in acute promyelocytic leukemia. Brit J Haematol 1997;96:314-321.
13. Schoch C, Haase D, Haferlach T, et al. Incidence and implication of additional chromosome aberrations in acute promyelocytic leukemia with translocation t(15;17)(q22;q21): a report on 50 patients. Br J Haematol 1996;94:493-500.